Accendatech USA Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme (NCT05053880) | Accendatech USA Inc. | 2021-09-22 |
Track Accendatech USA Inc. automatically
Every clearance here is in the API, with alerts when new ones post.